Literature DB >> 6408618

Polymicrobial bacteremia associated with lipid emulsion in a neonatal intensive care unit.

W R Jarvis, A K Highsmith, J R Allen, R W Haley.   

Abstract

Polymicrobial bacteremia developed in 5 of 20 infants in a neonatal intensive care unit during a 48-hour period; 2 infants died. Klebsiella pneumoniae serotypes 21 and 24 and Enterobacter cloacae were isolated from four infants, and K. pneumoniae serotype 24 and E. cloacae were isolated from the other infant. Case-control studies revealed an association between receipt of lipid emulsion on one day and the subsequent development of bacteremia (P = 0.0005). Epidemiologic evidence suggested that extrinsic contamination of the lipid emulsion bottles had occurred when the hands of a nurse became transiently colonized with these organisms while she was caring for an infant colonized with K. pneumoniae and E. cloacae. Repeated entry of the lipid emulsion bottle, which was used as a multidose medication, probably resulted in contamination. No further cases occurred after lipid emulsion administration practices were changed. We recommend that, except in a pharmacy where conditions for unit dose distribution exist, lipid emulsion should not be used as a multiple dose medication because repeated entry of the bottles increases the risk of contamination. Furthermore lipid emulsion from one container should be administered to only one infant.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6408618     DOI: 10.1097/00006454-198305000-00006

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


  12 in total

1.  Use of quantitative microbiological analyses to trace origin of contamination of parenteral nutrition solutions.

Authors:  Sucharit Bhakdi; Irene Krämer; Ekkehard Siegel; Bernd Jansen; Martin Exner
Journal:  Med Microbiol Immunol       Date:  2012-04-07       Impact factor: 3.402

2.  Microbial growth in neonatal intravenous fat emulsion administered over 12 versus 24 hours.

Authors:  Bethany M Dedonato; Lisa I Bickford; Ryan J Gates
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

3.  Safety of refrigerated storage of admixed parenteral fluids.

Authors:  D C Weil; P M Arnow
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

4.  Blood cultures in neonates with percutaneous central venous catheters.

Authors:  R Ramanathan; M Durand
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

5.  Microbial Contamination of Neonatal Injectable Lipid Emulsions at 12 and 24 Hours' Infusion Time With Evaluation of Infection Control Measures.

Authors:  Eman A Omran; Faten F Eisa; Wafaa M K Bakr
Journal:  J Pediatr Pharmacol Ther       Date:  2020 Jan-Feb

6.  Bacterial growth and endotoxin production in lipid emulsion.

Authors:  W R Jarvis; A K Highsmith
Journal:  J Clin Microbiol       Date:  1984-01       Impact factor: 5.948

7.  Growth of microorganisms in total parenteral nutrition solutions containing lipid.

Authors:  Takashi Kuwahara; Kazuyuki Shimono; Shinya Kaneda; Takumi Tamura; Masao Ichihara; Yoshifumi Nakashima
Journal:  Int J Med Sci       Date:  2010-05-18       Impact factor: 3.738

8.  Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers.

Authors:  C Doit; C Loukil; A-M Simon; A Ferroni; J-E Fontan; S Bonacorsi; P Bidet; V Jarlier; Y Aujard; F Beaufils; E Bingen
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Polymicrobial bloodstream infections in the neonatal intensive care unit are associated with increased mortality: a case-control study.

Authors:  Mohan Pammi; Danni Zhong; Yvette Johnson; Paula Revell; James Versalovic
Journal:  BMC Infect Dis       Date:  2014-07-14       Impact factor: 3.090

10.  Sudden Deaths of Neonates Receiving Intravenous Infusion of Lipid Emulsion Contaminated with Citrobacter freundii.

Authors:  Ji Yun Bae; Chang Kyung Kang; Su Jin Choi; Eunyoung Lee; Pyoeng Gyun Choe; Wan Beom Park; Nam Joong Kim; Eui Chong Kim; Myoung Don Oh
Journal:  J Korean Med Sci       Date:  2018-03-05       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.